Biogen Inc. (BVMF:BIIB34)
Brazil · Delayed Price · Currency is BRL 161.60
+1.76 (1.10%)
At close: Dec 3, 2025
Biogen Market Cap
Biogen has a market cap or net worth of 141.53 billion as of December 4, 2025. Its market cap has increased by 6.96% in one year.
Market Cap
141.53B
Enterprise Value
155.47B
Revenue
53.65B
Ranking
n/a
PE Ratio
16.51
Stock Price
161.60
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 149.34M to 141.53B, an increase of 94,671.64%. That is a compound annual growth rate of 22.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 141.53B | 2.69% |
| Dec 31, 2024 | 137.82B | -24.25% |
| Dec 29, 2023 | 181.94B | -13.70% |
| Dec 30, 2022 | 210.81B | 7.36% |
| Dec 31, 2021 | 196.36B | 0.35% |
| Dec 31, 2020 | 195.68B | -9.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 100.85B |
| Raia Drogasil | 40.19B |
| Hypera | 16.68B |
| Fleury | 8.67B |
| Odontoprev | 6.43B |
| Empreendimentos Pague Menos | 3.87B |
| Diagnósticos da América | 3.75B |
| Blau Farmacêutica | 2.33B |